country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-147717

Copy Link Print Information

CDK8-IN-7

CDK8-IN-7 (compound 12) is a potent and selective cyclin-dependent kinase 8 (CDK8) inhibitor with an K_d of 3.5 nM. CDK8-IN-7 shows cytotoxicity for MOLM-13, OCI-AML3, MV4-11, NRK and H9c2 cells with IC₅₀s of 5.9, 4.8, 5.4, 16.2, 12.5-25 µM, respectively. CDK8-IN-7 has the potential for the research of AML-cancer.

For research use only. We do not sell to patients.

CAS No.: 2415156-30-6
Formula: C₃₀H₄₀N₂
Molecular Weight:428.65

Storage:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (270 KB)

CDK8-IN-7 Chemical Structure

CAS No.: 2415156-30-6

Size

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- IC₅₀ & Target
- Cellular Effect
Chemical Information
Purity & Documentation
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

Description

IC₅₀ & Target^[1]

CDK8

3.5 nM (Kd)

All CDK Isoforms :

Cellular Effect

Cell Line	Type	Value	Description	References
H9c2	EC₅₀	12.5 μM Compound: 12	Cytotoxicity against rat H9c2 cells assessed as reduction in cell viability after 48 hrs by Hoechst 33342 staining-based microscopy and WST-1 assay Cytotoxicity against rat H9c2 cells assessed as reduction in cell viability after 48 hrs by Hoechst 33342 staining-based microscopy and WST-1 assay	[PMID: 32245563]
MOLM-13	EC₅₀	5.9 μM Compound: 12	Cytotoxicity against human MOLM13 cells assessed as reduction in cell viability after 48 hrs by Hoechst 33342 staining-based microscopy and WST-1 assay Cytotoxicity against human MOLM13 cells assessed as reduction in cell viability after 48 hrs by Hoechst 33342 staining-based microscopy and WST-1 assay	[PMID: 32245563]
MV4-11	EC₅₀	5.4 μM Compound: 12	Cytotoxicity against human MV4-11 cells assessed as reduction in cell viability after 48 hrs by Hoechst 33342 staining-based microscopy and WST-1 assay Cytotoxicity against human MV4-11 cells assessed as reduction in cell viability after 48 hrs by Hoechst 33342 staining-based microscopy and WST-1 assay	[PMID: 32245563]
NRK	EC₅₀	16.2 μM Compound: 12	Cytotoxicity against rat NRK cells assessed as reduction in cell viability after 48 hrs by Hoechst 33342 staining-based microscopy and WST-1 assay Cytotoxicity against rat NRK cells assessed as reduction in cell viability after 48 hrs by Hoechst 33342 staining-based microscopy and WST-1 assay	[PMID: 32245563]
OCI-AML-3	EC₅₀	4.8 μM Compound: 12	Cytotoxicity against human OCI-AML3 cells assessed as reduction in cell viability after 48 hrs by Hoechst 33342 staining-based microscopy and WST-1 assay Cytotoxicity against human OCI-AML3 cells assessed as reduction in cell viability after 48 hrs by Hoechst 33342 staining-based microscopy and WST-1 assay	[PMID: 32245563]

Chemical Information

CAS No. 2415156-30-6
Molecular Weight 428.65
Formula C₃₀H₄₀N₂
SMILES

C[C@@]12C(C3=CC=CC4=C3C=CN=C4)=CC[C@@]1([H])[C@]5([H])CC[C@@]6([H])C[C@H](N(C)C)CC[C@]6(C)[C@@]5([H])CC2
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (270 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Solum E, et al. New CDK8 inhibitors as potential anti-leukemic agents - Design, synthesis and biological evaluation. Bioorg Med Chem. 2020 May 15;28(10):115461. [Content Brief]

Calculators

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

100 mg

Get Quote In-stock